Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/260235 
Year of Publication: 
2018
Series/Report no.: 
Working Paper No. 2018:6
Publisher: 
Lund University, School of Economics and Management, Department of Economics, Lund
Abstract: 
This study exploits policy reforms in Swedish primary care to examine the effect of pay-for-performance (P4P) on compliance with hypertension drug guidelines among public and private health care providers. Providers in regions with P4P are compared to providers in other regions in a difference-in-differences analysis using data from the Swedish Prescription Register for the period 2005-2013. The results indicate that P4P improved guideline compliance regarding prescription of Angiotensin Converting Enzyme (ACE) inhibitors and Angiotensin Receptor Blockers (ARB). The effect is mainly driven by private providers, suggesting that policy makers should take ownership into account when designing incentives for health care providers.
Subjects: 
Pay-for-performance
Hypertension treatment
Ownership
Primary health care
JEL: 
D23
H73
I11
I18
J33
Document Type: 
Working Paper

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.